Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Altimmune (ALT) Preferred Stock Liabilities (2017 - 2018)

Altimmune (ALT) has disclosed Preferred Stock Liabilities for 2 consecutive years, with $510083.0 as the latest value for Q2 2018.

  • Quarterly Preferred Stock Liabilities changed N/A to $510083.0 in Q2 2018 from the year-ago period, while the trailing twelve-month figure was $510083.0 through Jun 2018, changed N/A year-over-year, with the annual reading at $9.3 million for FY2017, N/A changed from the prior year.
  • Preferred Stock Liabilities for Q2 2018 was $510083.0 at Altimmune, down from $6.0 million in the prior quarter.
  • The five-year high for Preferred Stock Liabilities was $9.3 million in Q4 2017, with the low at $510083.0 in Q2 2018.